Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559
For more info: http://chdo.realpennies.com
CHDT Corporation (OTC BB:CHDO) Current Price (0.02) DEERFIELD BEACH, FL----Dec 13, 2007 -- CHDT Corporation, a Florida corporation (OTC BB:CHDO.OB - News) (CHDT), announced today the appointment of Laurie Holtz as its Chief Financial Officer, effective December 10, 2007. CHDT Corp. (http://www.chdtcorp.com) is a holding company engaged through its operating subsidiaries in the following business lines: Capstone Industries, Inc. (www.capstoneindustries.com) is engaged in product development, manufacturing, distribution, logistics and product placement to importers, theme parks, and mass retail of souvenirs, gifts, and consumer products; and Overseas Building Supply (OBS) is engaged in distribution of building materials including but not limited to roof tiles, interior doors, and insulation materials. Reference of URLs in this press release does not incorporate said URLs or any of their contents in this press release.
For more info: http://amzo.realpennies.com
Amazon Biotech, Inc.
(OTC BB:AMZO) Current Price (0.10) NEW YORK, NY----Dec 12, 2007 -- Amazon Biotech, Inc. (OTC BB:AMZO.OB - News) (Frankfurt:B2D.F - News) has released the following update to shareholders.In the past six months, Amazon Biotech, Inc. has raised $215,000 in capital and is in negotiations for a further $2.3 Million. Upon the successful completion of funding the Company will focus on initiating phase I/II trials for its AIDS Drug AMZ0026. Amazon Biotech, Inc. is a natural plant pharmaceutical drug company, primarily developing immunomodulator drugs. AMZ0026 is the Company's first such drug to be used for the treatment of HIV/AIDS. The Company plans on initiating Phase I/II clinical studies of AMZ0026 in the near future, with an eventual goal of attracting a joint venture partner with a major pharmaceutical company in Phase III trials, or follow the FDA Fast Track program to market. Amazon Biotech specializes in natural plant pharmaceutical drugs and is focused on bringing healthier pharmaceutical drugs to market.
For more info: http://gmtib.realpennies.com
GreenMan Technologies, Inc.
(OTC BB:GMTIB) Current Price (0.52) SAVAGE, MN----Dec 12, 2007 -- GreenMan Technologies, Inc. (OTC BB:GMTI.OB - News), a leading recycler of over 12 million scrap tires per year in the United States, today announced that it plans to release the results for its fourth fiscal quarter and year ended September 30, 2007 on Monday, December 17, 2007, before the market opens. GreenMan will host a conference call later that morning at 11:00 AM EST in which we will discuss the results for the quarter and fiscal year ended September 30, 2007. To participate, please call 1-866-542-4265 and ask for the GreenMan call. A replay of the conference call can be accessed until 11:50 PM on January 17, 2008 by calling 1-800-408-3053 and entering pass code 3245581. GreenMan Technologies pursues technological processes and unique marketing programs to transform recycled materials into renewable fuel, alternative energy, recycled feedstock, and innovative recycled products. Over twelve million tires are collected and recycled annually into tire-derived fuel, tire-derived aggregate, and crumb rubber feedstock for playground, athletic track and field, and road surfacing. Through the company's Welch Products subsidiary, the company develops and markets branded products and services that provide schools and other political subdivisions viable solutions for safety, compliance, and accessibility. To learn more about all of the companies, please visit the following websites:
For more info: http://adli.realpennies.com
American Medical Technologies Inc (OTC BB:ADLI) Current Price (0.29) CORPUS CHRISTI, Texas--Dec 13--Consistent with its core strategic initiative of acquiring and selling quality dental and medical products through its international distribution network, American Medical Technologies Inc. (AMT) (OTCBB:ADLI - News) is pleased to announce the development of a global partnership with Discus Dental. Under the terms of this agreement AMT will act as international sales representative for the BriteSmile brand of professional tooth whitening products as well as the BreathRx brand of professional oral care products throughout the world. American Medical Technologies, Inc., headquartered in Corpus Christi, Texas, with satellite offices in Los Angeles and New York markets and sells unique dental and medical products to the dental and medical community through its established global federation of dealers and distributors. AMT's premier products, Contrast AM and Contrast PM, a professional tooth whitening product line, deliver excellent whitening results at a low cost. AMT was incorporated in Delaware in November 1989 and completed its initial public offering in June 1991. AMT changed its name from American Dental Technologies, Inc. on July 13, 2000. More information is available at www.americanmedicaltech.com.
Read our full disclaimer at: http://www.realpennies.com/start.html
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html
Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html
RealPennies .
Telephone: 1-800-940-6559
Matt /at/ realpennies.com
No comments:
Post a Comment